“…From 2010 to 2019, we collected clinical samples from NB (n = 9, retroperitoneal origin, mainly younger than 5 years old) ( 26 ), ganglioneuroblastoma (GNB, n = 2), olfactory neuroblastoma (ONB, n = 7), and retinoblastoma (RB, n = 6) patients in 1 st Affiliated Hospital of University of Science and Technology of Chima (USTC) and 2 nd Affiliated Hospital of Dalian Medical University (DMU) for IHC analysis ( Figures 1A–D ) to know the expression pattern of related proteins. Peripheral neuroblastic tumors are further classified based on their morphological features into NB, GNB, and ganglioneuroma (GN), known as the International Neuroblastoma Pathology Classification (INPC; Shimada system), which are relevant biologically and prognostically ( 27 ). Compared with ONB ( Figure 1C ) and RB ( Figure 1D ), the IHC staining of retroperitoneum-initiated NB showed significant higher (P < 0.05) expression of AR, SCAP, and especially the drug targets, HMGCR and CYP17A1 ( Figure 1E ).…”